Innovation Pharmaceuticals

Innovation Pharmaceuticals Provides a Comparative Perspective on Brilacidin’s Potential to Unlock the Huge Oral Mucositis Market
CP Wire
Mon, 09/24/18 - 03:34 pm
Innovation Pharmaceuticals
severe oral mucositis
Brilacidin
head and neck cancer
Innovation Pharmaceuticals Provides a Comparative Perspective on Brilacidin’s Potential to Unlock the Huge Oral Mucositis Market
Mon, 09/24/18 - 10:13 am
Innovation Pharmaceuticals
severe oral mucositis
Brilacidin
Innovation Provides Update on Ph II Trial of Brilacidin for Severe Oral Mucositis in Head and Neck Cancer
CP Wire
Wed, 05/9/18 - 09:56 am
Innovation Pharmaceuticals
Brilacidin-OM
clinical trials
oral mucositis
Innovation Provides Update on Ph II Trial of Brilacidin for Severe Oral Mucositis in Head and Neck Cancer
Wed, 05/9/18 - 09:43 am
Innovation Pharmaceuticals
Brilacidin
oral mucositis
severe oral mucositis
More Promising Data from Innovation Pharmaceutical's Phase 2 Brilacidin Oral Mucositis Study
CP Wire
Mon, 04/16/18 - 11:31 pm
Innovation Pharmaceuticals
severe oral mucositis
Brilacidin
More Promising Data from Innovation Pharmaceutical's Phase 2 Brilacidin Oral Mucositis Study
Mon, 04/16/18 - 01:44 pm
Innovation Pharmaceuticals
Innovation Pharmaceuticals Reports on Successful Phase II Trial of Brilacidin-OM for Oral Mucositis
CP Wire
Mon, 04/9/18 - 03:39 pm
Innovation Pharmaceuticals
Brilacidin-OM
head and neck cancer
severe oral mucositis